Engitix, a British BioTech company tarobtaining the extracellular matrix (ECM) to develop transformative therapies for cancer and fibrosis, today announced…
Read More
BioRestorative Therapies Faces Revenue Drop But Keeps Wall Street’s Favor
What’s going on here? BioRestorative Therapies just posted a rough quarter, with much lower revenue and steeper losses – but…
Read More
As millions await approved therapies, myTomorrows strengthens its global patient-access mission with €25 million
myTomorrows, a Dutch HealthTech company that connects patients with possible pre-approval treatments, today announced the close of a €25 million…
Read More
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies
Leveraging its Accelerator™ Drug Development, 360° CDMO and CMO solutions, Thermo Fisher will provide clinical research services for Lyndra’s phase…
Read More
